IJCS | Volume 31, Nº3, May/ June 2018

272 Wiefels et al. Evaluation of Desynchronization with GSPECT in Patients with Heart Failure International Journal of Cardiovascular Sciences. 2018;31(3)264-273 Original Article 5. Rossi A, Rossi G, Piacenti M, Startari U, Panchetti L, Morales MA. The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Heart Vessels. 2008;23(4):217-23. 6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developedwith the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. 7. Cubillos-Garzon LA, Casas JP, Morillo CA, Bautista LE. Congestive heart failure in LatinAmerica: the next epidemic. AmHeart J. 2004;147(3):412-7. 8. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108(21):2596-603. 9. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 2002;39(2):194-201. 10. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomizedmulticenter study. Am J Cardiol. 1999;83(5B):130D-135D. 11. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, De Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113(7):969-76. 12. International Atomic Energy Agency (IAEA). IAEAAnnual Report 2013. Vienna (Austria); 2013. [Acesso em 2017 fev 9]. Disponível em: <https:// www.iaea.org/About/Policy/GC/GC58/GC58Documents/English/ gc58-3-att1_en.pdf>. 13. Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;12(6):687-95. 14. Reis CW, Nascimento EA, Ribeiro ML, Dias FB, Wanderley AP, Batista LA, et al. Applicability of myocardial perfusion scintigraphy in the evaluation of cardiac synchronization. Arq Bras Cardiol: Imagem cardiovasc. 2017;30(2):54-63. 15. Chen J, Garcia EV, Bax JJ, IskandrianAE, Borges-Neto S, Soman P. SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony. J Nucl Cardiol. 2011;18(4):685-94. 16. Trimble MA, Borges-Neto S, Honeycutt EF, Shaw LK, Pagnanelli RJ, Chen J, et al. Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. J Nucl Cardiol. 2008;15(5):663-70. 17. Poole JE, Singh JP, Birgersdotter-Green U. QRS duration or QRS morphology what really matters in cardiac resynchronization therapy. J Am Coll Cardiol. 2016;67(9):1104-17. 18. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA). 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070-118. 19. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108(21):2596-603. 20. Bleeker GB, Schalij MJ, Molhoek SG, Verwey HF, Holman ER, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol. 2004;15(5):544-9. 21. Henneman MM, Chen J, Dibbets-Schneider P, Stokkel MP, Bleeker GB, Ypenburg C, et al. Can LV dyssynchrony as assessedwith phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med. 2007;48(7):1104-11. 22. AlJaroudi, W, Aggarwal, H, Venkataraman R, Heo J, Iskandrian AE, Hage FG. Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease. J Nucl Cardiol. 2010;17(6):1058-64. 23. Aggarwal H, AlJaroudi WA, Mehta S, Mannon R, Heo J, Iskandrian AE, et al. The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2014;21(4):739-46. 24. Zafrir N, Nevzorov R, Bental T, Strasberg B, Gutstein A, Mats I, et al. Prognostic value of left ventricular dyssynchrony by myocardial perfusion-gated SPECT in patients with normal and abnormal left ventricular functions. J Nucl Cardiol. 2014;21(3):532-40. 25. Zafrir N, Bental T, Strasberg B, Solodky A, Mats I, Gutstein A, et al. Yield of left ventricular dyssynchrony by gated SPECT MPI in patients with heart failure prior to implantable cardioverter-defibrillator or cardiac resynchronization therapy with a defibrillator: Characteristics and prediction of cardiac outcome. J Nucl Cardiol. 2017;24(1):122-9. 26. Aguadé-Bruix S, Romero-Farina G, Candell-Riera J, Pizzi MN, García- Dorado D. Mechanical dyssynchrony according to validated cut-off values using gated SPECTmyocardial perfusion imaging. J Nucl Cardiol. 2016 Nov 1. [Epub ahead of print].